External verification and improvement of the Neo-Bioscore staging system in a Chinese cohort.

ABSTRACT:

Background

Accurately predicting outcomes for patients with breast cancer receiving neoadjuvant chemotherapy (NAC) is critical for clinical decisions. Prognostic models applicable to the Chinese population remain limited. The Neo-Bioscore staging system has been utilized as a predictive model for survival of breast cancer patients after NAC. This study aimed to validate the applicability of Neo-Bioscore in a Chinese population and develop an improved staging system based on it to predict prognosis of Chinese patients more accurately.

Methods

This study retrospectively collected clinicopathological and survival data in patients receiving NAC from February 2005 to August 2018 in PLA General Hospital. Discrimination, calibration and clinical usefulness were used to assess model

SUBMITTER: Geng R 

PROVIDER: S-EPMC9263773 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature